With only a few weeks before the start of its first California trial involving Vioxx, Merck & Co. is seeking to have one of the cases thrown out on statute of limitations grounds.
The move comes shortly after Merck was hit with a recent jury verdict in Texas, and after damaging new data surfaced about the potential dangers of the pain reliever.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
